SEARCH

SEARCH BY CITATION

References

  • Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL & Bartkowski H (1986). Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17, 472476.
  • Biernaskie J, Corbett D, Peeling J, Wells J & Lei H (2001). A serial MR study of cerebral blood flow changes and lesion development following endothelin-1-induced ischemia in rats. Magn Reson Med 46, 827830.
  • Carey RM (2005). Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension 45, 840844.
  • Cote F, Do TH, Laflamme L, Gallo JM & Gallo-Payet N (1999). Activation of the AT2 receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J Biol Chem 274, 3168631692.
  • Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, De Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S & Wedel H (2002). Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359, 9951003.
  • Dai WJ, Funk A, Herdegen T, Unger T & Culman J (1999). Blockade of central angiotensin AT1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30, 23912398; discussion 2398–2399.
  • Faure S, Bureau A, Oudart N, Javellaud J, Fournier A & Achard JM (2008). Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors. J Hypertens 26, 20082015.
  • Garcia JH, Wagner S, Liu KF & Hu XJ (1995). Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26, 627634; discussion 635.
  • Glendenning ML, Lovekamp-Swan T & Schreihofer DA (2008). Protective effect of estrogen in endothelin-induced middle cerebral artery occlusion in female rats. Neurosci Lett 445, 188192.
  • Gonzalez CL & Kolb B (2003). A comparison of different models of stroke on behaviour and brain morphology. Eur J Neurosci 18, 19501962.
  • Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK & Katovich MJ (2007). Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1–7). Am J Physiol Heart Circ Physiol 292, H736H742.
  • Groth W, Blume A, Gohlke P, Unger T & Culman J (2003). Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens 21, 21752182.
  • Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmäki K, Dahlöf B, De Faire U, Mörlin C, Karlberg BE, Wester PO & Björck JE (1999). Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353, 611616.
  • Horiuchi M, Akishita M & Dzau VJ (1999). Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 33, 613621.
  • Inada Y, Wada T, Ojima M, Sanada T, Shibouta Y, Kanagawa R, Ishimura Y, Fujisawa Y & Nishikawa K (1997). Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 19, 10791099.
  • Ito T, Yamakawa H, Bregonzio C, Terrón JA, Falcón-Neri A & Saavedra JM (2002). Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 33, 22972303.
  • Iwai M, Liu HW, Chen R, Ide A, Okamoto S, Hata R, Sakanaka M, Shiuchi T & Horiuchi M (2004). Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 110, 843848.
  • Kagiyama T, Glushakov AV, Sumners C, Roose B, Dennis DM, Phillips MI, Ozcan MS, Seubert CN & Martynyuk AE (2004). Neuroprotective action of halogenated derivatives of l-phenylalanine. Stroke 35, 11921196.
  • Kagiyama T, Kagiyama S & Phillips MI (2003). Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats. Regul Pept 110, 241247.
  • Krikov M, Thone-Reineke C, Muller S, Villringer A & Unger T (2008). Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats. J Hypertens 26, 544552.
  • Li H, Gao Y, Freire CD, Raizada MK, Toney GM & Sumners C (2006). Macrophage migration inhibitory factor in the PVN attenuates the central pressor and dipsogenic actions of angiotensin II. FASEB J 20, 17481750.
  • Li J, Culman J, Hörtnagl H, Zhao Y, Gerova N, Timm M, Blume A, Zimmermann M, Seidel K, Dirnagl U & Unger T (2005). Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 19, 617619.
  • Li JM, Mogi M, Iwanami J, Min LJ, Tsukuda K, Sakata A, Fujita T, Iwai M & Horiuchi M (2008). Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density. Stroke 39, 20292036.
  • Liu H, Kitazato KT, Uno M, Yagi K, Kanematsu Y, Tamura T, Tada Y, Kinouchi T & Nagahiro S (2008). Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies. J Hypertens 26, 14351445.
  • Lu Q, Zhu YZ & Wong PT (2005). Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats. Neuroreport 16, 19631967.
  • Lucius R, Gallinat S, Rosenstiel P, Herdegen T, Sievers J & Unger T (1998). The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med 188, 661670.
  • McCarthy CA, Vinh A, Callaway JK & Widdop RE (2009). Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke 44, 14821489.
  • Makino I, Shibata K, Ohgami Y, Fujiwara M & Furukawa T (1996). Transient upregulation of the AT2 receptor mRNA level after global ischemia in the rat brain. Neuropeptides 30, 596601.
  • Nishimura Y, Ito T & Saavedra JM (2000). Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31, 24782486.
  • Papademetriou V, Farsang C, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P & Zanchetti A (2004). Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). J Am Coll Cardiol 44, 11751180.
  • Reinecke K, Lucius R, Reinecke A, Rickert U, Herdegen T & Unger T (2003). Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-κB. FASEB J 17, 20942096.
  • Sharkey J & Butcher SP (1995). Characterisation of an experimental model of stroke produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle cerebral artery. J Neurosci Methods 60, 125131.
  • Stenman E & Edvinsson L (2004). Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 35, 970974.
  • Stier CT Jr, Adler LA, Levine S & Chander PN (1993). Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens Suppl 11, S37S42.
  • Takada J, Ibayashi S, Ooboshi H, Ago T, Ishikawa E, Kamouchi M, Kitazono T & Iida M (2006). Valsartan improves the lower limit of cerebral autoregulation in rats. Hypertens Res 29, 621626.
  • Viswanathan M & Saavedra JM (1992). Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing. Peptides 13, 783786.
  • Walther T, Olah L, Harms C, Maul B, Bader M, Hörtnagl H, Schultheiss HP & Mies G (2002). Ischemic injury in experimental stroke depends on angiotensin II. FASEB J 16, 169176.
  • Windle V, Szymanska A, Granter-Button S, White C, Buist R, Peeling J & Corbett D (2006). An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat. Exp Neurol 201, 324334.
  • Yamamoto E, Tamamaki N, Nakamura T, Kataoka K, Tokutomi Y, Dong YF, Fukuda M, Matsuba S, Ogawa H & Kim-Mitsuyama S (2008). Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke 39, 30493056.